Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor: RedDress Ltd.
Study ID: NCT04699305
Status: Recruiting

Apply to this trial

Conditions

Cutaneous Wounds

Eligibility Criteria

Sex: ALL
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Interventions

ActiGraft — DEVICE
Whole blood clot (WBC) gel

Study Details

Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.

Key Dates

First listed: Jan 7, 2021
Start date: Feb 14, 2019
Status verified: Jul 2025
Primary completion: Jul 1, 2026
Completion: Jan 31, 2027

Study Design

Enrollment: 500 participants (estimated)

Arms

Arm: ActiGraft
Whole blood clot (WBC) gel

Primary Outcome Measure

Percentage area reduction (PAR) at 4 weeks [ Time Frame: 4 weeks ]

Central Contacts

Sharon Sirota
+972545800765
[email protected]

Locations (1)

Facility	City	State	ZIP	Site coordinators
Wound Care Experts	Las Vegas	Nevada	89128	Naz Wahab, M.D

Find similar trials in Las Vegas, NV

By research site

Wound Care Experts· Las Vegas, NV